Giving Compass' Take:
- Chloe E. Bird at RAND Corporation makes a case for funding for research specifically for women's health.
- How can targeted funding help underscore the importance of women's health issues? In what ways can philanthropy support this research?
- Read more about women's health in the U.S. and abroad.
What is Giving Compass?
We connect donors to learning resources and ways to support community-led solutions. Learn more about us.
For far too long, the medical sciences have treated men and women as interchangeable subjects, favoring men's health for funding and the male body for study. This approach creates a problem, not just for women but everyone. Not only are we missing a large and critical slice of the population, we are leaving an unknown amount of science unexplored.
What's more, by underfunding the study of women's health issues, we've left a tremendous amount of money on the table. In fact, in nearly three-quarters of cases where a disease primarily effects one gender, the so-called “men's diseases” are overfunded, while the “women's diseases” are dramatically underfunded. Even a slight increase in capital invested in basic research into women's health would unleash staggering returns that would capture the attention of anyone on Wall Street or in Silicon Valley.
Women, after all, make up more than half the U.S. population and about half the workforce. Women are more likely than men to be caregivers, and make 80% of all health care decisions. Yet the medical sciences continue to underfund studies focused on women, even among diseases that affect women most of all. This is, quite simply, inefficient science.
Cardiovascular disease, for example, is the number one killer of women in the United States, but only about a third of participants in clinical trials for new treatments for cardiovascular disease are female. Almost two-thirds (PDF) of the 6.2 million people suffering with Alzheimer's are women, but in most animal studies of the disease, researchers haven't reported the sex of the animal they're studying.
We can't know what we're missing if we aren't even paying attention to it—so how might things look different if we were to start improving funding for research into women's health, even slightly more than we currently fund it?
I recently helped oversee a study—commissioned by Women's Health Access Matters, a nonprofit advocacy organization that works to increase awareness of and funding for women's health issues—that ran a series of simulations looking at the return on investment we might expect if the National Institute of Health budget for studies specifically assessing the health of women were doubled. For example, we examined what might happen if the budget for Alzheimer's research into women specifically went from $288 million to $576 million. In these simulations, we conservatively assumed that this budgetary increase would deliver merely the slightest of health improvements, just 0.01% for Alzheimer's and coronary artery disease, and 0.1% for rheumatoid arthritis, over 30 years.
Read the full article about women's health issues by Chloe E. Bird at RAND Corporation.